Lupin Appoints Jeffrey Kindler and Alfonso 'Chito' Zulueta As Independent Directors
May 09, 2024•over 1 year ago
Company
Lupin Limited
MumbaiMedicalHealth CareBiotechnologyDescription
Lupin, a major pharmaceutical company, has announced the appointment of Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors to its board. Kindler brings extensive experience from his leadership roles at Pfizer, McDonald's Corporation, and General Electric Company, while Zulueta has a wealth of knowledge from his tenure at Eli Lilly and Company.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months